Altimmune, Inc.ALTNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank21
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-94.49M
↓ 43% vs avg
Percentile
P21
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-66.07M
Historical baseline
PeriodValueYoY Change
TTM$-94.49M+8.4%
2024$-103.17M-7.6%
2023$-95.93M-9.3%
2022$-87.74M+9.5%
2021$-96.91M-76.9%
2020$-54.80M-155.3%
2019$-21.46M+49.9%
2018$-42.83M+17.7%
2017$-52.05M-362.0%
2016$-11.26M-